Palvella Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Go back to Palvella Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update| (NASDAQ: PVLA) | Delayed: 154.32 +2.89 (1.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $151.43 | 52 Week High | $ | |||
| Open | $154.78 | 52 Week Low | $ | |||
| Day High | $156.79 | P/E | N/A | |||
| Day Low | $151.55 | EPS | $ | |||
| Volume | 153,871 | |||||

